berzosertib
Showing 1 - 12 of 12
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
- Lurbinectedin
- Berzosertib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United
Active, not recruiting
- Metastatic Fallopian Tube Carcinoma
- +11 more
- Berzosertib
- +4 more
-
Phoenix, Arizona
- +13 more
Dec 2, 2022
Metastatic Lung Neuroendocrine Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in
Active, not recruiting
- Metastatic Lung Neuroendocrine Neoplasm
- +6 more
- Berzosertib
- +3 more
-
Duarte, California
- +8 more
Jul 16, 2022
Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)
Active, not recruiting
- Small-cell Lung Cancer
- Berzosertib
- Topotecan
-
Santa Rosa, California
- +47 more
Jun 24, 2022
Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,
Recruiting
- Lung Non-Small Cell Squamous Carcinoma
- Stage IV Lung Cancer AJCC v8
- Berzosertib
- +6 more
-
Los Angeles, California
- +34 more
Jan 20, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Berzosertib
- +3 more
-
Duarte, California
- +22 more
Jan 3, 2023
Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell
Active, not recruiting
- Head and Neck Carcinoma of Unknown Primary
- +19 more
- Berzosertib
- +3 more
-
Duarte, California
- +18 more
Aug 24, 2022
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage
Active, not recruiting
- Clinical Stage III Gastric Cancer AJCC v8
- +7 more
- Berzosertib
- +4 more
-
Duarte, California
- +30 more
Jan 7, 2023
Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Metastatic Ureter Urothelial
Active, not recruiting
- Metastatic Bladder Urothelial Carcinoma
- +3 more
- Berzosertib
- +2 more
-
Phoenix, Arizona
- +38 more
Jul 13, 2022
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
- Avelumab
- Berzosertib
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022